affront
发表于 2025-3-21 18:49:52
书目名称Applications of Pharmacokinetic Principles in Drug Development影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0159535<br><br> <br><br>书目名称Applications of Pharmacokinetic Principles in Drug Development读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0159535<br><br> <br><br>
自然环境
发表于 2025-3-21 23:20:01
Sekundärprophylaxe in der Gefäßchirurgie assure in vivo bioavailability / bioequivalence (BA/BE). Assessing the risk / benefit criteria and global regulatory requirements that may include human studies for formulation or chemistry changes is a key component when determining the ultimate benefit of contemplated product changes.
刚毅
发表于 2025-3-22 04:13:30
http://reply.papertrans.cn/16/1596/159535/159535_3.png
interlude
发表于 2025-3-22 06:46:43
http://reply.papertrans.cn/16/1596/159535/159535_4.png
Pepsin
发表于 2025-3-22 10:37:00
http://reply.papertrans.cn/16/1596/159535/159535_5.png
Servile
发表于 2025-3-22 13:05:09
Textbook 2004s of topics presented deal with the application of these tools to everyday decisions that a pharmaceutical scientist encounters. The ability to integrate these topics using PK and PO methods has optimized drug development pathways in the clinic. New technologies in the areas of in vitro assays that
BOLUS
发表于 2025-3-22 17:12:48
K. J. Husfeldt,R. Raschke,M. Mühee to market is only 10-20% (Prentis et al., 1988; Kennedy, 1997). While many factors contribute to a high failure rate, it is somewhat surprising that poor pharmacokinetic properties, such as poor oral bioavailability, account for almost half of the failures in clinical development.
arrhythmic
发表于 2025-3-22 23:25:09
H. Schumacher,N. Diehm,J. R. Allenberges and the width of the therapeutic window between effective and toxic blood concentrations, specific subpopulations might require a dose regimen which diverges from the population average regimen. Unmasking and exploring these special populations during clinical development is one of the focuses of clinical pharmacology.
反省
发表于 2025-3-23 03:56:02
http://reply.papertrans.cn/16/1596/159535/159535_9.png
增长
发表于 2025-3-23 05:43:49
http://reply.papertrans.cn/16/1596/159535/159535_10.png